Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline plus CO2 laser for burn scars
IRCT20230613058476N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pentoxifylline in burn scar (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Improvement of Vancouver Scar Scale score, Tolerability of treatment and 2 more. Started Jun 2020; status: completed.
02
Drugs
pentoxifylline
03
Conditions
burn scar
Beyond the preview
Go deeper on IRCT20230613058476N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230613058476N1.